| Literature DB >> 19691776 |
Yasuhiro Asahina1, Hiroyuki Nakanishi, Namiki Izumi.
Abstract
Radiofrequency ablation (RFA) is one of the best curative treatments for hepatocellular carcinoma in selected patients, and this procedure can be applied either percutaneously or laparoscopically. Although the percutaneous approach is less invasive and is considered the first choice, RFA with laparoscopic guidance is highly recommended for patients with a relative contraindication for percutaneous RFA, such as lesions adjacent to the gastrointestinal tract, gallbladder, bile duct and heart. Recent advances in laparoscopic ultrasound have widened the indication for laparoscopic ablation. In the present paper, we review the indications, advantages, prognosis and safety of laparoscopic RFA for hepatocellular carcinoma.Entities:
Mesh:
Year: 2009 PMID: 19691776 DOI: 10.1111/j.1443-1661.2009.00844.x
Source DB: PubMed Journal: Dig Endosc ISSN: 0915-5635 Impact factor: 7.559